Clinical and Experimental Rheumatology

《Clinical and Experimental Rheumatology》是 1983 年创刊的风湿病学期刊，编辑部设在意大利比萨，由同名出版公司独立经营。

刊物覆盖肌肉骨骼疾病、关节炎与结缔组织病的临床、实验与转化研究，并以每年若干期主题专号组织重点方向。

2025 年期刊影响因子为 3.2，五年影响因子为 2.9，在风湿病学 58 种期刊中排第 21 位。

Scope

• Rheumatoid arthritis is a central subject, from pathogenesis and autoantibodies to treat-to-target trials and remission criteria.类风湿关节炎是核心题目，从发病机制、自身抗体一直到达标治疗试验与缓解标准。
• Spondoarthritis coverage includes axial disease, psoriatic arthritis, imaging of sacroiliitis and the classification of early disease.脊柱关节炎的覆盖包括中轴病变、银屑病关节炎、骶髂关节影像以及早期疾病的分类。
• Systemic lupus erythematosus papers address organ involvement, biomarkers, pregnancy and long-term damage accrual.系统性红斑狼疮论文讨论器官受累、生物标志物、妊娠以及长期损伤累积。
• Sjögren's disease is treated as a major theme, with glandular function, lymphoma risk and systemic manifestations as recurring topics.舍格伦病被当作重要主题，腺体功能、淋巴瘤风险与全身表现是反复出现的题目。
• Systemic sclerosis research covers skin and lung involvement, microvascular disease and the design of trials in a heterogeneous population.系统性硬化研究覆盖皮肤与肺受累、微血管病变以及在异质人群中设计试验。
• Vasculitis papers span large-vessel, ANCA-associated and medium-vessel disease, including imaging and remission maintenance.血管炎论文涵盖大血管、ANCA 相关与中等血管病变，包括影像与维持缓解。
• Inflammatory myopathies are covered together with the International Myositis Society, from autoantibody profiles to muscle imaging.炎性肌病与国际肌炎学会合作覆盖，从自身抗体谱到肌肉影像。
• Behçet's disease and autoinflammatory conditions form an annual issue, with epidemiology, ocular disease and biologic therapy.白塞病与自身炎症性疾病构成年度专号，涉及流行病学、眼病与生物制剂治疗。
• Fibromyalgia and related syndromes receive a dedicated issue that mixes clinical trials with conceptual and diagnostic debate.纤维肌痛及相关综合征拥有专门刊期，把临床试验与概念、诊断争论放在一起。
• Osteoporosis, crystal arthritis and osteoarthritis are covered where they intersect with inflammatory rheumatic disease.骨质疏松、晶体性关节炎与骨关节炎在与炎性风湿病交叉时被覆盖。
• Paediatric and transitional rheumatology papers address juvenile idiopathic arthritis and the transfer of care to adult services.儿童与过渡期风湿病论文讨论幼年特发性关节炎以及向成人服务的转介。
• Imaging studies report ultrasound, magnetic resonance and conventional radiography for diagnosis, monitoring and damage assessment.影像研究报道超声、磁共振与常规X线在诊断、监测和损伤评估中的用途。
• Biomarkers and immunology papers connect laboratory measurement to clinical phenotype rather than reporting associations alone.生物标志物与免疫学论文把实验室测量与临床表型相连，而不是只报告相关性。
• Randomised trials, pragmatic studies and registry analyses are published when they inform treatment choice in routine practice.随机试验、实用性研究与登记分析在能够指导日常治疗选择时被发表。
• Environmental rheumatology examines air pollution, occupational exposures, climate and infection as triggers or modifiers of disease.环境风湿病学考察空气污染、职业暴露、气候与感染作为疾病的诱因或修饰因素。
• Rehabilitation, patient education and self-management are treated as clinical outcomes rather than ancillary topics.康复、患者教育与自我管理被当作临床结局，而不是附属题目。
• Reviews and "one year in review" articles summarise annual progress in each major disease area.综述与年度回顾文章总结各主要疾病领域的年度进展。
• Case series are considered when they describe a rare manifestation or a complication that changes management.病例系列在描述会改变处理方式的罕见表现或并发症时被考虑。
• Letter to the Editor Rheumatology, known as LER, publishes short commentaries and dissenting views alongside the main journal.刊物另设致编辑来信栏目（简称 LER），与正刊并行发表短评与不同意见。

History

• The journal was founded in 1983 in Pisa and has remained independent of a large commercial publisher.刊物于 1983 年在比萨创刊，一直独立于大型商业出版集团。
• Its early volumes concentrated on clinical and experimental research in rheumatic and connective tissue diseases.早期各卷集中于风湿病与结缔组织病的临床和实验研究。
• The first monothematic supplement appeared in 2001 and was devoted to Behçet's disease and familial Mediterranean fever.第一本主题增刊于 2001 年问世，主题是白塞病与家族性地中海热。
• A vasculitis supplement began in 2003, followed by fibromyalgia and scleroderma issues in 2009.血管炎增刊于 2003 年开始，随后在 2009 年出现纤维肌痛与硬皮病专号。
• A Sjögren's disease issue started in 2018, and the myositis issue became the official organ of the International Myositis Society.舍格伦病专号于 2018 年启动，肌炎专号后来成为国际肌炎学会的正式刊物。
• The journal absorbed the online forum Letter to the Editor Rheumatology, which now runs as a section within it.刊物吸纳了此前的致编辑来信在线平台，该平台如今作为其中一个栏目运行。
• Publication moved from six issues a year to a monthly rhythm, with supplements added to the regular numbers.出版节奏从每年六期转为按月发行，并在正刊之外增加增刊。
• The impact factor was 4.473 in 2021 and 4.862 in 2022, then 3.4 in 2023, 3.3 in 2024 and 3.2 in 2025.影响因子在 2021 年为 4.473，2022 年为 4.862，2023 年为 3.4，2024 年为 3.3，2025 年为 3.2。
• The 2025 report placed it in Q2 for Rheumatology at rank 21 of 58, with a JCI rank of 18 of 58.2025 年报告把它列为风湿病学 Q2，58 种中排第 21 位，JCI 排名为 58 种中的第 18 位。
• The same report counted 10987 citations, 196 articles and 238 citable items.同一份报告统计被引 10987 次，载文 196 篇，可引用条目 238 项。
• Gold open access is limited to 1.53 percent of content, and authors pay a page charge of 150 euros per printed page.金色开放获取仅占内容的 1.53%，作者按每印刷页 150 欧元支付版面费。
• Letters to the editor carry a separate charge of 300 euros, while solicited articles are exempt from page charges.读者来信另收 300 欧元，约稿文章免收版面费。
• The journal is indexed in MEDLINE and PubMed, the Science Citation Index Expanded and Scopus.刊物被 MEDLINE 与 PubMed、科学引文索引扩展版以及 Scopus 收录。
• A linked publication, the Journal of Environmental Rheumatology, carries work on environmental triggers under the same editorial office.关联刊物 Journal of Environmental Rheumatology 在同一编辑部之下发表环境诱因研究。
• The journal publishes articles ahead of print online, then assigns them to the corresponding monothematic issue.文章先在线预出版，随后归入相应的主题专号。

Editors

• Stefano Bombardieri, a rheumatologist in Pisa, is editor-in-chief and signs the journal's editorial correspondence.比萨的风湿病学家 Stefano Bombardieri 担任主编，刊物的编辑通信由他签署。
• Luisa Marconcini is managing editor and handles submitted manuscripts, advertising and business correspondence.Luisa Marconcini 任编辑部主任，处理投稿、广告与业务通信。
• Wendy Doherty is production editor and manages galley proofs and the final correction stage.Wendy Doherty 任生产编辑，负责校样与最终订正环节。
• Hasan Yazici in Istanbul and Eldad Ben-Chetrit in Jerusalem are co-editors of the Behçet's disease and autoinflammatory issue.伊斯坦布尔的 Hasan Yazici 与耶路撒冷的 Eldad Ben-Chetrit 共同主编白塞病与自身炎症性疾病专号。
• Piercarlo Sarzi-Puttini in Milan, Jacob N. Ablin in Tel Aviv and Winfried Häuser in Germany co-edit the fibromyalgia issue.米兰的 Piercarlo Sarzi-Puttini、特拉维夫的 Jacob N. Ablin 与德国的 Winfried Häuser 共同主编纤维肌痛专号。
• Michele Bombardieri in London and Hendrika Bootsma in Groningen co-edit the Sjögren's disease issue.伦敦的 Michele Bombardieri 与格罗宁根的 Hendrika Bootsma 共同主编舍格伦病专号。
• Miguel A. González-Gay in Spain and Loïc Guillevin in France co-edit the annual vasculitis issue.西班牙的 Miguel A. González-Gay 与法国的 Loïc Guillevin 共同主编年度血管炎专号。
• Mazen M. Dimachkie, Peter Korsten, Jens Schmidt and Anneke J. van der Kooi co-edit the myositis issue.Mazen M. Dimachkie、Peter Korsten、Jens Schmidt 与 Anneke J. van-der-Kooi 共同主编肌炎专号。
• Theodore Pincus of Rush University edits the Contemporary Topics in Clinical Rheumatology series.拉什大学的 Theodore Pincus 主编 Contemporary Topics in Clinical Rheumatology 系列。
• The scleroderma board includes P.J. Clements, C.P. Denton, O. Distler, C. Ferri, L. Czirjak and U. Müller-Ladner.硬皮病编委会包括 P.J. Clements、C.P. Denton、O. Distler、C. Ferri、L. Czirjak 与 U. Müller-Ladner。
• The vasculitis and Sjögren's boards include A. Berti, T.A. Kermani, A.N. Baer and C.P. Mavragani.血管炎与舍格伦病编委会包括 A. Berti、T.A. Kermani、A.N. Baer 与 C.P. Mavragani。
• The Behçet's and fibromyalgia boards include K. Aksu, M. Melikoglu, L. Arnold and B. Danneskiold-Samsoe.白塞病与纤维肌痛编委会包括 K. Aksu、M. Melikoglu、L. Arnold 与 B. Danneskiold-Samsoe。
• The myositis board includes L. Cavagna, H. Chinoy, M. Needham, T.H. Chung, N. Pipitone and L.G. Rider.肌炎编委会包括 L. Cavagna、H. Chinoy、M. Needham、T.H. Chung、N. Pipitone 与 L.G. Rider。
• Manuscripts are sent to external rheumatologists and laboratory scientists, and statistical advice is sought for trial reports.稿件送给外部风湿病学家与实验室科学家评审，试验报告另请统计意见。
• The editorial office in Pisa coordinates the monothematic issues with their co-editors and guest editors.比萨编辑部与各专号共同主编及客座编辑协调出版安排。